He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
In this video, Raymond Cross, MD, from the University of Maryland, addresses the most challenging extraintestinal manifestations among patients with inflammatory bowel disease.
In this video, Michael Banks, MD, discusses how the discovery of this enzyme's role in neurodegenerative diseases could lead to the development of AEP-inhibitors and provide new treatment options for...
